Theraclion, S.A.S. (ALTHE) Declined -5.23% on Jan 14

Shares of Theraclion, S.A.S. (EPA:ALTHE) last traded at 0.652, representing a move of -5.23%, or -0.036 per share, on volume of 21,831 shares. After opening the trading day at 0.688, shares of Theraclion, S.A.S. traded in a close range. Theraclion, S.A.S. currently has a total float of 8.41M shares and on average sees 16,679 shares exchange hands each day. The stock now has a 52-week low of 0.606 and high of 4.9.

Euronext Paris: Driving France’s Economic Prospects

France is one of Europe’s pride not just in the tourism front but most importantly, in the corporate world. One of the main reasons that Europe is immensely growing as an economy today is France. Its trading relations with Theraclion, S.A.S. and other companies help both sides to grow further. The nation’s economic potentials cannot be undermined especially when they reflect in its own stable equity market.

Euronext Paris in History

Euronext Paris is part of a broader, pan-European stock exchange that stretches in five of the biggest European cities that include Paris, London, Lisbon, Brussels, and Amsterdam— the Euronext. It works with Theraclion, S.A.S. as well. Some of the main Euronext indices include the AEX, AScX, CAC 40, Next 150, among others.

The Amsterdam Stock Exchange, the Brussels Stock Exchange, and the Paris Bourse had joined together on September 22, 2000, forming the first pan-European stock exchange. Two years later, the Bolsa de Valores de Lisboa e Porto (BVLP) had joined the Euronext. The foundation of a bigger, consolidated European stock exchange signifies the efforts of the European Union (EU) to maximize its resources and leverage better growth opportunities. Nearly two decades later and the Euronext continues to live up to its founding principle and mission— to drive the European economy towards meaningful success.

The CAC 40 is the free-float market capitalization-weighted index tracking the top 40 stocks on Euronext Paris. It represents a crucial aspect of the French economy as well as that of the European economy. Theraclion, S.A.S. had to prove its reliability to appear at the market.

Prior to becoming a free-float market capitalization-weighted index on December 1, 2003, the CAC 40 had used to measure stocks based on overall market capitalization. Its name comes from an old automated trading system on the Euronext, CotationAssistéeenContinu.

The Index Steering Committee reviews the components of the CAC 40 every third Friday of March, June, September, and December. During these review dates, the Index Steering Committee limits the weights of each stock at 15%. The top 100 companies in terms of 12-month free-float market capitalization and share turnover are determined every quarter. From these 100 companies, the 40 most significant components are selected to make up the CAC 40.

Euronext Paris by the Numbers

As of the first quarter of 2014, the Euronext already had nearly €3 trillion of market capitalization with more than 1,000 companies.

The CAC 40 had reached an all-time high of nearly 7,000 on September 4, 2000, a few days before the establishment of the Euronext. Meanwhile, it had posted an all-time low of below 900 in January 1988.

The movement on Euronext Paris is in increments of 0.50. Stocks are weighted quarterly using a base value of 1,000, which was determined on December 31, 1987.

The margin requirement is usually 2% while the minimum trade size requirement is one index. As part of the EU, the main trading currency on Euronext Paris is euro.

Euronext Paris is one of the most influential stock exchanges not just in Europe but in the world as well. It boasts with stability and strong, long-term growth prospects. That being said, investing in Euronext Paris is a primary consideration among novice and experienced investors alike. Investors may be interested in Theraclion, S.A.S. stocks.

More notable recent Theraclion, S.A.S. (EPA:ALTHE) news were published by: which released: “This Coal Lobbyist Should Not Run the E.P.A. – The New York Times” on January 14, 2019, also with their article: “EPA, IDEM approve disposal of contaminated material in East Chicago facility, drawing criticism – Chicago Tribune” published on December 20, 2018, published: “Dems Question EPA On Wheeler Confirmation Hearing Prep – Law360” on January 12, 2019. More interesting news about Theraclion, S.A.S. (EPA:ALTHE) were released by: and their article: “Shrewsbury stormwater fee coming; other towns find other ways to cover costs – Worcester Telegram” published on January 14, 2019 as well as‘s news article titled: “Analysis | The Energy 202: What you need to know about Trump’s quiet order to fight wildfires – The Washington Post” with publication date: January 14, 2019.

Theraclion, S.A.S. develops, manufactures, and markets the Echopulse medical device for the non-invasive and outpatient treatment of breast fibroadenomas and benign thyroid nodules. The company has market cap of 5.49 million EUR. It offers an echotherapy solution that combines high-intensity focused ultrasound therapy with ultrasound as a system for locating target areas for the non-invasive treatment of benign tumours. It currently has negative earnings.

(adsbygoogle = window.adsbygoogle || []).push({});

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.